Bayer CropScience Ltd
Bayer CropScience is engaged in Agri Care business which primarily includes manufacture, sale and distribution of insecticides, fungicides, herbicide and various other agrochemical products and corn seeds.[1]
- Market Cap ₹ 24,399 Cr.
- Current Price ₹ 5,429
- High / Low ₹ 7,197 / 4,217
- Stock P/E 43.0
- Book Value ₹ 634
- Dividend Yield 2.58 %
- ROCE 24.8 %
- ROE 19.9 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 86.9%
Cons
- Stock is trading at 8.56 times its book value
- The company has delivered a poor sales growth of 8.68% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE 500 Nifty 500 BSE MidCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3,188 | 3,660 | 2,769 | 2,803 | 2,710 | 3,167 | 3,609 | 4,261 | 4,734 | 5,140 | 5,103 | 5,473 | |
2,768 | 3,144 | 2,334 | 2,389 | 2,300 | 2,684 | 2,883 | 3,450 | 3,923 | 4,216 | 4,147 | 4,784 | |
Operating Profit | 419 | 516 | 435 | 414 | 410 | 483 | 726 | 812 | 812 | 924 | 956 | 690 |
OPM % | 13% | 14% | 16% | 15% | 15% | 15% | 20% | 19% | 17% | 18% | 19% | 13% |
91 | 88 | 82 | 70 | 39 | 51 | -64 | 69 | 112 | 168 | 79 | 120 | |
Interest | 5 | 5 | 10 | 7 | 11 | 10 | 14 | 13 | 13 | 22 | 20 | 17 |
Depreciation | 65 | 25 | 25 | 29 | 33 | 44 | 65 | 74 | 64 | 80 | 74 | 85 |
Profit before tax | 441 | 574 | 482 | 448 | 404 | 480 | 583 | 794 | 847 | 990 | 941 | 707 |
Tax % | 34% | 33% | 35% | 35% | 26% | 30% | 19% | 38% | 24% | 23% | 21% | 20% |
290 | 383 | 315 | 291 | 300 | 337 | 474 | 493 | 645 | 758 | 740 | 568 | |
EPS in Rs | 79.06 | 104.59 | 89.13 | 82.31 | 87.41 | 98.18 | 105.58 | 109.72 | 143.58 | 168.71 | 164.77 | 126.38 |
Dividend Payout % | 7% | 20% | 19% | 21% | 21% | 18% | 24% | 105% | 104% | 77% | 85% | 99% |
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | 9% |
3 Years: | 5% |
TTM: | 7% |
Compounded Profit Growth | |
---|---|
10 Years: | 4% |
5 Years: | 0% |
3 Years: | -2% |
TTM: | -23% |
Stock Price CAGR | |
---|---|
10 Years: | 4% |
5 Years: | 0% |
3 Years: | 1% |
1 Year: | -10% |
Return on Equity | |
---|---|
10 Years: | 21% |
5 Years: | 23% |
3 Years: | 24% |
Last Year: | 20% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 37 | 37 | 35 | 35 | 34 | 34 | 45 | 45 | 45 | 45 | 45 | 45 |
Reserves | 1,706 | 1,996 | 1,804 | 2,021 | 1,744 | 2,205 | 2,528 | 2,505 | 2,479 | 2,667 | 2,804 | 2,806 |
0 | 0 | 0 | 0 | 0 | 0 | 2 | 26 | 86 | 74 | 47 | 105 | |
645 | 740 | 597 | 769 | 756 | 1,310 | 1,262 | 1,663 | 1,742 | 1,893 | 1,701 | 2,290 | |
Total Liabilities | 2,387 | 2,773 | 2,437 | 2,825 | 2,535 | 3,549 | 3,836 | 4,239 | 4,353 | 4,679 | 4,597 | 5,246 |
228 | 322 | 290 | 342 | 334 | 440 | 468 | 425 | 468 | 462 | 414 | 588 | |
CWIP | 217 | 1 | 17 | 24 | 36 | 47 | 56 | 76 | 98 | 109 | 119 | 0 |
Investments | 4 | 29 | 68 | 50 | 0 | 0 | 41 | 52 | 38 | 41 | 54 | 35 |
1,939 | 2,422 | 2,062 | 2,410 | 2,164 | 3,062 | 3,270 | 3,686 | 3,749 | 4,066 | 4,010 | 4,622 | |
Total Assets | 2,387 | 2,773 | 2,437 | 2,825 | 2,535 | 3,549 | 3,836 | 4,239 | 4,353 | 4,679 | 4,597 | 5,246 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
282 | 200 | 206 | 157 | 121 | 433 | 666 | 687 | 216 | 609 | 952 | 262 | |
-290 | 485 | 16 | -8 | 38 | -113 | -29 | 7 | 64 | 83 | 0 | 86 | |
-480 | -42 | -590 | -73 | -581 | -158 | -148 | -556 | -703 | -613 | -656 | -619 | |
Net Cash Flow | -488 | 644 | -367 | 76 | -421 | 162 | 489 | 138 | -424 | 79 | 296 | -272 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 47 | 57 | 53 | 72 | 89 | 81 | 73 | 65 | 77 | 69 | 69 | 63 |
Inventory Days | 98 | 85 | 169 | 178 | 175 | 294 | 206 | 226 | 235 | 268 | 222 | 254 |
Days Payable | 51 | 40 | 52 | 67 | 67 | 164 | 101 | 142 | 127 | 129 | 87 | 118 |
Cash Conversion Cycle | 94 | 102 | 171 | 184 | 197 | 211 | 177 | 149 | 185 | 208 | 204 | 199 |
Working Capital Days | 88 | 53 | 92 | 104 | 134 | 116 | 77 | 62 | 87 | 89 | 80 | 93 |
ROCE % | 24% | 31% | 25% | 23% | 22% | 25% | 30% | 31% | 31% | 34% | 34% | 25% |
Documents
Announcements
-
Intimation To Holders Of Physical Securities To Furnish PAN, KYC Details And Nomination As Per Applicable SEBI Circular
6 Jun - Bayer CropScience urges physical shareholders to update PAN, KYC, nomination per SEBI May-June 2024 circulars.
-
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
28 May - Clarification on increased share volume; no undisclosed price sensitive info, market-driven movement.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
28 May - Read with Schedule III Part A Para A of SEBI LODR Regulations, 2015, please find attached herewith the newspaper advertisement for the audited financial results …
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
28 May - Secretarial Compliance Report for FY ended March 31, 2025; minor filing delay promptly rectified.
-
Clarification sought from Bayer CropScience Ltd
28 May - Exchange has sought clarification from Bayer CropScience Ltd on May 28, 2025, with reference to Movement in Volume.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Aug 2024Transcript PPT
-
Jun 2023Transcript PPT
-
Jun 2022Transcript PPT
-
Nov 2021Transcript PPT
-
May 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
May 2020TranscriptNotesPPT
-
Nov 2019TranscriptNotesPPT
-
May 2019TranscriptNotesPPT
-
Nov 2018TranscriptNotesPPT
-
Jun 2018TranscriptNotesPPT
-
Aug 2017TranscriptNotesPPT
-
Feb 2017TranscriptNotesPPT
-
Jul 2016TranscriptNotesPPT
-
Nov 2015TranscriptNotesPPT
Business Areas